Skip to main content

Search results for "survey response"

Viewing 21 - 40 of 1,428 results by relevance

Traffic Capacity Level of Service: Adaptations and Usage  (2025)

Practices to Enhance Resiliency of Existing Roadway and Embankment Culverts  (2025)

Safety Evaluation of On-Street Bicycle Facility Design Features  (2025)

Consensus Study Report

Ocean Acoustics Education and Expertise  (2025)

Practices for Collecting, Managing, and Using Light Detection and Ranging Data  (2025)

Operational and Service Factors When Integrating or Consolidating ADA Paratransit and On-Demand Services  (2025)

Consensus Study Report

Response to the Centers for Medicare & Medicaid Services CY 2026 Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies Proposed Rule  (2025)

Consensus Study Report

Economic and Social Mobility: New Directions for Data, Research, and Policy  (2025)

Risk Management at State DOTs: Building Momentum and Sustaining the Practice  (2025)

Bridge Construction Inspection Training Resources and Practices  (2025)

Consensus Study Report

Cybercrime Classification and Measurement  (2025)

Construction Stormwater Program Management, Tracking, Reporting, and Compliance  (2025)

Transportation Emergency Response Application (TERA): Migration Options Beyond 2025  (2025)

Open-Book Pricing Practices for Construction Manager/General Contractor and Progressive Design-Build Projects  (2025)

Proceedings

U.S. Research Data Summit: Strengthening Cooperation Across Organizations and Sectors: Proceedings of a Workshop  (2025)

Incorporating Technologies into Airport In-Terminal Concessions Programs: A Primer  (2025)

Tracking Safety Leading Indicators to Improve DOT Employee Safety Performance  (2025)

Microtransit Solutions in Rural Communities: On-Demand Alternatives to Dial-a-Ride Services and Unproductive Coverage Routes  (2025)

Legal Impacts to Airports from State Legalization of Cannabis  (2025)

Consensus Study Report

Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations  (2025)